Bursitis Treatment That Targets
Your Bursa — Not Your Whole Body
Yes, topical anti-inflammatory cream works for bursitis. Bursae are fluid-filled sacs that cushion bones, tendons, and muscles near joints. The most commonly affected bursae — hip (trochanteric), shoulder (subacromial), and knee (prepatellar) — are all superficial structures within topical delivery range. Topical NSAIDs deliver anti-inflammatory medication directly to the inflamed bursa.
Bursitis is inflammation of the bursae — small, fluid-filled cushions that reduce friction between bones, tendons, and muscles at your joints. When a bursa becomes irritated from overuse, pressure, or injury, it swells and produces pain that can make everyday movement miserable. Hip bursitis disrupts sleep. Shoulder bursitis limits overhead reach. Knee bursitis makes kneeling impossible.
The bursae most prone to inflammation — trochanteric (hip), subacromial (shoulder), and prepatellar (knee) — sit within 1-3cm of the skin surface. That shallow depth puts them squarely within topical delivery range. Medication absorbs through the skin directly to the inflamed structure, without passing through your stomach first.
Bursitis is inflammation of a bursa — a small, fluid-filled sac that cushions the space between bones, tendons, and muscles near joints. The body has over 150 bursae, but the ones most commonly inflamed are the trochanteric bursa (hip), subacromial bursa (shoulder), and prepatellar bursa (knee).
- •Bursitis is inflammatory by definition — NSAID mechanism is directly relevant
- •Superficial bursae (hip, shoulder, knee) sit within 1-3cm of the skin surface
- •Topical NSAIDs listed in treatment guidelines (Medscape, Stanford, NYU Langone)
- •Diclofenac gel, ketoprofen, and ibuprofen gel all indicated for bursitis
- •Ketorolac analgesic potency approximately 5x that of diclofenac
- •Cochrane review: topical NSAIDs NNT of 1.8 for 50% pain reduction
Why Your Joint Won't Stop Hurting
A bursa is a thin, slippery sac filled with a small amount of fluid. It acts as a cushion and lubricant between structures that would otherwise grind against each other — bone against tendon, tendon against muscle, bone against skin. When working properly, you never notice them. When inflamed, they make every movement a negotiation with pain.
Bursitis happens when repetitive motion, sustained pressure, or acute injury irritates the bursa lining. The sac produces excess fluid, swells, and presses against surrounding structures. Hip bursitis wakes you up every time you roll onto that side. Shoulder bursitis turns reaching for a cabinet into a sharp, catching pain. Knee bursitis makes kneeling — or even walking stairs — feel like grinding against glass.
The critical advantage for topical treatment: bursitis is inflammatory by definition. The problem is localized inflammation in a superficial structure. That means an anti-inflammatory medication delivered directly to the site — through the skin, not through your entire digestive system — addresses the mechanism where it matters. Topical NSAID delivery to the inflamed bursa is mechanistically logical and guideline-supported.
"My hip bursitis flares up every time I increase my running mileage. I was taking naproxen daily and my doctor told me to stop because of kidney risk. The prescription gel goes right on my hip — I can actually train through it now." — Forum user
What People Try for Bursitis — And Why It Falls Short
Bursitis treatment usually follows a predictable path: rest, pills, ice, injection, repeat. Most options either mask symptoms or treat the whole body for inflammation in one joint.
A systemic drug for a localized problem. Your entire GI tract, kidneys, and liver process the medication when you only need anti-inflammatory action at one bursa. Long-term daily use for recurring bursitis carries real organ risks.
Effective for acute flares — cortisone reduces bursal inflammation quickly. But repeated injections weaken surrounding tissue (tendons, cartilage) and are limited to 3-4 per year per site. Each injection requires an office visit and carries infection risk.
Ice reduces swelling temporarily and rest removes the aggravating stimulus. But neither delivers actual anti-inflammatory medication to the bursa. The inflammation persists beneath the surface, and pain returns the moment you resume activity.
PT addresses biomechanics, strengthens surrounding muscles, and can reduce recurrence. But PT alone doesn't provide acute anti-inflammatory action during a flare. You need to calm the inflammation before rehab exercises are tolerable.
Topical Bursitis Treatment: The Clinical Evidence
Bursitis is localized inflammation in a superficial structure. Topical NSAIDs deliver anti-inflammatory medication directly to where it's needed. This isn't theoretical — clinical guidelines and peer-reviewed data support it.
Ketorolac delivers approximately 5x the analgesic potency of diclofenac (Voltaren) — the difference between OTC and prescription-strength topical anti-inflammatory.
Topical diclofenac achieved a number-needed-to-treat of 1.8 — fewer than 2 patients treated for 1 to achieve 50% pain reduction in musculoskeletal conditions.
Topical NSAIDs deliver medication to the site with 5-17x less drug entering your bloodstream than oral pills. Minimal GI, kidney, and cardiovascular exposure.
Topical vs. Oral: Why Delivery Method Matters for Bursitis
The bursae most prone to inflammation are superficial — the trochanteric, subacromial, and prepatellar bursae all sit within 1-3cm of the skin. Topical NSAIDs penetrate through the skin and concentrate at the inflamed bursa. Multiple clinical resources — including Medscape, Stanford, and NYU Langone — list topical NSAIDs as a treatment option for bursitis. Systemic absorption is 5-17x lower than oral NSAIDs.
Medication penetrates skin directly over the inflamed bursa. Concentrates anti-inflammatory action where the inflammation is.
- Bursae are superficial (1-3cm) — ideal for topical penetration
- 5-17x lower bloodstream absorption
- GI side effects equal to placebo
- No kidney or cardiovascular burden
- Self-applied daily — no office visits or needles
Pill dissolves in stomach, enters bloodstream, distributes everywhere. Only a fraction reaches the one bursa you're trying to treat.
- Treats entire body for one inflamed bursa
- Full systemic drug exposure
- GI bleeding risk increases with duration
- Kidney function declines over years
- Cardiovascular risk with long-term use
Prescription Bursitis Cream + Daily Comfort
Prescription-strength anti-inflammatory for bursitis flares. Daily magnesium as a comfort product for general muscle relaxation. The topical NSAID is the evidence-based treatment for bursitis.
Prescription-strength topical ketorolac. Originally formulated for the Boston Red Sox. Applied directly over the inflamed bursa — hip, shoulder, or knee. The medication absorbs through the skin to the superficial bursa structure. Topical NSAIDs are listed in clinical guidelines for bursitis treatment. No GI side effects, no systemic exposure.
- Prescription-strength ketorolac (topical NSAID)
- 5x analgesic potency of diclofenac (Voltaren)
- Bursae are superficial — ideal for topical delivery
- Compounded per order by US pharmacy
- Online consultation included
Skincare-formulated topical magnesium. A daily comfort product for general muscle relaxation. Note: there is no clinical evidence that topical magnesium treats bursitis specifically — it is not a substitute for the prescription-strength topical NSAID above.
- Premium transdermal magnesium delivery
- Daily comfort product for general muscle relaxation
- Fast-absorbing, non-greasy formula
- Formulated like skincare, not drugstore
- No prescription needed
Clinical Evidence for Topical Bursitis Treatment
Real guidelines, real data. Not marketing claims — clinical resources and peer-reviewed evidence supporting topical delivery for bursitis.
Multiple clinical resources — Medscape, Stanford Health Care, and NYU Langone — list topical NSAIDs as a treatment option for bursitis. Topical diclofenac gel, ketoprofen, and ibuprofen gel are all indicated. The superficial location of the most commonly affected bursae makes topical delivery mechanistically logical — the medication reaches the inflamed structure without systemic distribution.
Cochrane review data shows topical diclofenac achieved a number-needed-to-treat (NNT) of 1.8 for 50% pain reduction in acute musculoskeletal conditions. This means fewer than 2 patients need to be treated for 1 to achieve clinically significant pain relief — an exceptionally strong result. Bursitis, as an acute inflammatory musculoskeletal condition with superficial anatomy, falls squarely within this evidence base.
Ketorolac delivers approximately 5x the analgesic potency of diclofenac — the active ingredient in Voltaren. While OTC topical diclofenac (1%) can provide some relief for bursitis, prescription-strength ketorolac delivers substantially more anti-inflammatory power to the inflamed bursa. That potency difference matters when the bursa is swollen and producing significant pain.
A 2019 meta-analysis in Drugs & Aging confirmed that topical NSAIDs show gastrointestinal toxicity equivalent to placebo. Systemic absorption is 5-17x lower than oral NSAIDs. For bursitis — a condition that often recurs and may require repeated courses of anti-inflammatory treatment — this safety profile is significant. You can treat the flare without accumulating systemic organ risk.
Topical NSAID vs. Other Bursitis Treatments
| Feature | Topical NSAID (Ketro RX) | Oral NSAIDs | Cortisone Injection | Rest / Ice |
|---|---|---|---|---|
| Delivery | Direct to bursa through skin | Systemic (whole body) | Injection into bursa area | Surface cooling only |
| Mechanism | Anti-inflammatory (NSAID) | Anti-inflammatory (NSAID) | Immunosuppressant (steroid) | Vasoconstriction (ice) |
| GI Side Effects | Equivalent to placebo | Significant with daily use | None (injected) | None |
| Tissue Safety | No tissue weakening | No tissue weakening | Repeated injections weaken tissue | No effect |
| Frequency | Daily self-application | Daily oral dose | 3-4x/year max per site | Multiple times daily |
| Potency | Prescription-strength | Prescription available | High (localized steroid) | N/A (no medication) |
| Office Visit Required | No — online consultation | No (OTC) or Yes (Rx) | Yes — practitioner required | No |
| Systemic Absorption | 5-17x lower than oral | Full systemic exposure | Low (localized) | None |
| Origin | Boston Red Sox formulation | Generic pharmaceutical | Generic pharmaceutical | N/A |
Bursitis Treatment FAQ
Topical Relief for Other Conditions
The ACR recommends topical NSAIDs as first-line for knee and hand osteoarthritis. Same efficacy as oral, fraction of the risk.
Superficial tendon inflammation at the elbow. 2025 guidelines recommend topical NSAIDs as first-line for tendinitis.
Desk tension, repetitive strain, and shoulder impingement. The same overuse patterns that trigger bursitis often cause neck and shoulder pain.
Find Your Relief
Targeted bursitis treatment. Anti-inflammatory medication applied directly to the bursa — not through your entire body first.
This content is for informational purposes only and does not constitute medical advice. Consult a healthcare provider before starting any new treatment. Individual results may vary. Ketro RX Pain Gel requires a prescription. Clinical data referenced from published peer-reviewed studies and clinical treatment guidelines.